Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5
Yanqun Wang(Second Affiliated Hospital of Guangzhou Medical University), Jincun Zhao(ShanghaiTech University), Baiping Sun, Deyong Song(Beike Biotechnology (China)), Beibei Yu, Chuangchuang Dong, Ruxi Qi(Southern University of Science and Technology), Qiao‐Ping Wang(Sun Yat-sen University), Guangying Du(Luye Pharma (China)), Jun Lü(Nanchang Center for Disease Control and Prevention), Xiaodan Ni, Maoqin Duan(National Institutes for Food and Drug Control), Yanyan Zhao, Mengqi Zong, Xiaomin Ma(Southern University of Science and Technology), Jianxia Feng, Changlin Dou(Beike Biotechnology (China)), Hongguang Xu, Xiaoping Yu(Chongqing Medical University), An Yan(Southern University of Science and Technology), Muding Rao, Zheng Liu(Jilin University), Chunna You(Luye Pharma (China)), Lan Wang(National Medical Products Administration), Huimin Zhang(West Virginia University), Lu Zhang(China Pharmaceutical University), Min Li(Weifang Medical University), Hong Liu(Sun Yat-sen University), Ying Li(Harbin Medical University), Yanan Zhang(University of Kansas), Shuo Liu(Wuhan University), Rui Li(Max Planck Institute of Immunobiology and Epigenetics), Hua Jiang(State Key Laboratory of Oncogene and Related Genes), Haifeng Zhao, Xin Shao(Guangdong Medical College), Jie Jiao(Capital Medical University), Yanxia Wang(First Affiliated Hospital of Guangzhou Medical University), Zhenduo Shen(Shandong Institute of Business and Technology), Yuanzhu Gao(Southern University of Science and Technology), Jing Han(Hebei Medical University), Fanhao Meng
Cited by 22
Related Papers
The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study
|The Lancet Global Health|2020|1.6k
Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13
|Cell|2011|817
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
|Cell|2022|538
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
|Cell Reports|2020|450